Gel Column Agglutination Test system market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The market is segmented by Test Type, Type (Portable, Bench-Top), End-User, and Geography.

Market Snapshot

gel column agglutination test system market analysis
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.5 %
gel column agglutination test system market key players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The gel column agglutination test system market is expected to register a CAGR of 5.5% during the forecast period. Health awareness among the population and high health expenditure by the government are some of the factors driving the overall market. The gel column agglutination test gives high accuracy and more rapid results that will further lead to the adoption of these tests and boost the revenue growth of the market. These tests are widely used in the pharmaceutical industry for diagnostic purposes. Moreover, several applications in the field of research laboratories are also propelling the market as these tests are easy to conduct, the basic principle is being used wherein based on the size, the gel column separates agglutinated blood from non-agglutinated red blood cells leading to the high demand of this systems in the laboratories. Furthermore, technological advancements, increasing diagnostic centers, and hospital blood bank assists may also contribute to the gel column agglutination test market.

Scope of the Report

Gel column agglutination test system is an automated technology that works on the gel column which acts as a filter that separates agglutinated red blood cells in the centrifugation. These systems are used for diagnostic and pharmaceutical industries.

By Test Type
Antibody Screening
Serology Test
By Type
By End-User
Pharmaceuticals Industry
Hospital Blood Banks
Diagnostic Centers
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Benchtop ​Segment is Expected to Hold largest Market Share in the Gel Column Agglutination Test System market

The Benchtop gel column agglutination system is expected to hold the largest share attributing to its convenience, ease of use with a faster performance which promotes the adoption of these types for testing in the pharmaceutical industries. Gel Column agglutination test system comprises several tests such as antibody screening, Serology test, direct antiglobulin test (DAT), RH type test, ABO test which is extensively used for diagnostic purposes and has been major factors for the segment growth.

In addition, with the increasing R&D expenditure worldwide, and several applications with this system such as blood grouping, red cell antibody detection, and identification and other serological applications, results in propelling the growth of the gel column agglutination test system market.

gel column agglutination test system market trends

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global gel column agglutination test system market due to the growing number of diagnostic centers and high health awareness in this region. Moreover, technological advancements in the gel column agglutination testing system are leading to the increasing adoption of these testing methods which further lead to dominant the market in this region. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

gel column agglutination test system market forecast

Competitive Landscape

The market studied is moderately competitive and there are several international companies that are having an active presence in this market. Some of the companies which are currently gaining attention include, Bio-Rad Laboratories, Inc., Grifols, QIAGEN, Ortho Clinical Diagnostics, Tulip Diagnostics (P) Ltd, Thermo Fisher Scientific, 3B scientific and Mira Vista Labs.

Table of Contents


    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Health Awareness and High Health Expenditure

      2. 4.2.2 High Accuracy and Rapid Results

    3. 4.3 Market Restraints

      1. 4.3.1 Cost Effectiveness

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Test Type

      1. 5.1.1 Antibody Screening

      2. 5.1.2 Serology Test

      3. 5.1.3 DAT

      4. 5.1.4 Others

    2. 5.2 By Type

      1. 5.2.1 Portable

      2. 5.2.2 Bench-Top

    3. 5.3 By End-User

      1. 5.3.1 Pharmaceuticals Industry

      2. 5.3.2 Hospital Blood Banks

      3. 5.3.3 Diagnostic Centers

    4. 5.4 Geography

      1. 5.4.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.4.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Bio-Rad Laboratories Inc.

      2. 6.1.2 Ortho Clinical Diagnostics

      3. 6.1.3 QIAGEN NV

      4. 6.1.4 Grifols

      5. 6.1.5 Tulip Diagnostics (P) Ltd

      6. 6.1.6 Thermo Fisher Scientific

      7. 6.1.7 3B scientific

      8. 6.1.8 Mira Vista Labs

    2. *List Not Exhaustive

Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The undefined market is studied from 2018 - 2026.

The undefined is growing at a CAGR of 5.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

QIAGEN, Ortho Clinical Diagnostics, Grifols, Bio-Rad Laboratories, Inc., Tulip Diagnostics (P) Ltd are the major companies operating in undefined.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!